|

Vorasidenib Clinical Trials

3 actively recruiting trials across 1 location

Also known as: AG-881, S095032

Other2 trials

Vorasidenib Maintenance for IDH Mutant Astrocytoma
Phase 3
Vorasidenib in CNS WHO Grade 2 IDH-mutant Diffuse Glioma

Birmingham, Alabama1 trial

Study of Vorasidenib and Pembrolizumab Combination in Recurrent or Progressive IDH-1 Mutant Glioma

University of Alabama at Birmingham

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.